Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1–4 brain metastases

Z Chen, L Zhou, M Zhao, K Cao, Y Li, X Liu, Y Hou, L Li… - BMC cancer, 2022 - Springer
Purpose Stereotactic radiosurgery (SRS) has become a standard approach for the treatment
of patients with few metastatic brain lesions. However, the optimal treatment approach for …

Comparison between stereotactic radiosurgery and whole‑brain radiotherapy for 10‑20 brain metastases from non‑small cell lung cancer

T Mizuno, K Takada, T Hasegawa… - Molecular and …, 2019 - spandidos-publications.com
The efficacy and safety of stereotactic radiosurgery (SRS) in comparison with whole brain
radiotherapy (WBRT) for brain metastases (BMs) remains unclear. The present study …

Upfront and Repeated Stereotactic Radiosurgery in Patients With Brain Metastases From NSCLC

AS Krämer, S Adeberg, D Kronsteiner, L König… - Clinical Lung Cancer, 2023 - Elsevier
Introduction Approximately 40% of non-small-cell lung cancer (NSCLC) patients develop
brain metastases (BM). Stereotactic radiosurgery (SRS) instead of whole-brain radiotherapy …

Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer

D Kaul, A Angelidis, V Budach, P Ghadjar, M Kufeld… - Radiation …, 2015 - Springer
Background Our purpose was to analyze the long-term clinical outcome and to identify
prognostic factors after Linac-based stereotactic radiosurgery (SRS) or fractionated …

Stereotactic radiosurgery in the management of patients with brain metastases of non-small cell lung cancer: indications, decision tools and future directions

D Hartgerink, B Van der Heijden… - Frontiers in …, 2018 - frontiersin.org
Brain metastases (BM) frequently occur in non-small cell lung cancer (NSCLC) patients.
Most patients with BM have a limited life expectancy, measured in months. Selected patients …

Stereotactic radiosurgery (SRS) alone versus whole brain radiotherapy plus SRS in patients with 1 to 4 brain metastases from non-small cell lung cancer stratified by …

S Qie, Y Li, H Shi, L Yuan, L Su, X Zhang - Medicine, 2018 - journals.lww.com
Background: The present study aims to assess the therapeutic effect of whole brain
radiotherapy (WBRT) for brain metastases from non-small cell lung cancer stratified by …

Choice of radiotherapy modality for the combined treatment of non-small cell lung cancer with brain metastases: whole-brain radiation therapy with simultaneous …

X Dong, K Wang, H Yang, Y Li, Y Hou, J Chang… - Frontiers in …, 2023 - frontiersin.org
Purpose To compare Whole-brain radiation therapy with simultaneous integrated boost
(WBRT+ SIB) to stereotactic radiosurgery (SRS) for non-small cell lung cancer (NSCLC) with …

Whole brain radiation therapy plus focal radiation boost may generate better survival benefit for brain metastases from non-small cell lung cancer

M Ni, W Liu, A Jiang, Y Wang, Y Sheng, H Zeng… - Frontiers in …, 2020 - frontiersin.org
Background Owing to improved systemic therapies, the survival of patients with non-small
cell lung cancer (NSCLC) was prolonged, and the risk of brain metastases was …

[HTML][HTML] Limited cerebral metastases in NSCLC: a literature review of SRS versus whole-brain radiotherapy

M Grenzelia, A Zygogianni, D Grapsa… - Cancer Diagnosis & …, 2022 - ncbi.nlm.nih.gov
Background/Aim: Brain metastases (BMs) are common in patients with non-small cell lung
cancer (NSCLC). Whole-brain radiotherapy (WBRT) with or without corticosteroid use has …

Stereotactic radiosurgery with or without whole-brain radiation therapy for limited brain metastases: a secondary analysis of the North Central Cancer Treatment Group …

TM Churilla, KV Ballman, PD Brown, EL Twohy… - International Journal of …, 2017 - Elsevier
Purpose To determine whether whole-brain radiation therapy (WBRT) is associated with
improved overall survival among non-small cell lung cancer (NSCLC) patients with …